The potential of biomaterials for central nervous system cellular repair.
Neurochem Int
; 144: 104971, 2021 03.
Article
em En
| MEDLINE
| ID: mdl-33515647
ABSTRACT
The central nervous system (CNS) can be injured or damaged through a variety of insults including traumatic injury, stroke, and neurodegenerative or demyelinating diseases, including Alzheimer's disease, Parkinson's disease and multiple sclerosis. Existing pharmacological and other therapeutics strategies are limited in their ability to repair or regenerate damaged CNS tissue meaning there are significant unmet clinical needs facing patients suffering CNS damage and/or degeneration. Through a variety of mechanisms including neuronal replacement, secretion of therapeutic factors, and stimulation of host brain plasticity, cell-based repair offers a potential mechanism to repair and heal the damaged CNS. However, over the decades of its evolution as a therapeutic strategy, cell-based CNS repair has faced significant hurdles that have prevented its translation to widespread clinical practice. In recent years, advances in cell technologies combined with advances in biomaterial-based regenerative medicine and tissue engineering have meant there is very real potential for many of these hurdles to be overcome. This review will provide an overview of the main CNS conditions that lend themselves to cellular repair and will then outline the potential of biomaterial-based approaches for improving the outcome of cellular repair in these conditions.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Materiais Biocompatíveis
/
Encéfalo
/
Doenças do Sistema Nervoso Central
/
Terapia Baseada em Transplante de Células e Tecidos
/
Regeneração Nervosa
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Neurochem Int
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Irlanda